Home›Screener›CRSP›Profile
D
43/100

CRISPR Therapeutics

CRSPGene Editing
← Signals View
📋
Analyst Summary
✓ VERIFIED2026-04-11

CRISPR Therapeutics (CRSP) is the lead sponsor of 5 active clinical trials listed on ClinicalTrials.gov[3], including 2 Phase 2[1], 4 Phase 1[2].

CRSP has 10 Form 4 insider filings recorded at the SEC in the past 30 days[4].

Sources

  1. ClinicalTrials.gov (2026-04-11) ↗
  2. ClinicalTrials.gov (2026-04-11) ↗
  3. ClinicalTrials.gov (2026-04-11) ↗
  4. SEC EDGAR · 0001674416 (2026-04-11) ↗
🏛
Upcoming Catalysts
exagamglogene autotemcel — transfusion-dependent beta-thal
2026-10-15
in 133d
🔬
Clinical Trials
5
NCT05565248Diabetes Mellitus, Diabetes Mellitus, Type 1, Glucose Metabolism Disorders, Metabolic Disease, Endocrine System Diseases, Autoimmune Diseases, Immune System Diseases
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT05643742B-cell Lymphoma, Non-Hodgkin Lymphoma, B-cell Malignancy, Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL), Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Large B-cell Lymphoma
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06208878Hematologic Malignancy, Solid Malignancy
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT06925542SLE (Systemic Lupus), Lupus Erythematosus, Systemic, Lupus Nephritis, Systemic Sclerosis, Inflammatory Myopathy, Idiopathic, Myositis, Diffuse Cutaneous Systemic Sclerosis
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
NCT07491172Cardiovascular, Metabolic Disease, Dyslipidemias, Lipid Disorder, Hypertriglyceridemia, Heterozygous Familial Hypercholesterolemia (HeFH), Homozygous Familial Hypercholesterolemia (HoFH), Severe Hypertriglyceridemia (sHTG), Mixed Hyperlipemia, Hypercholesterolaemia
Source ↗
clinicaltrials_gov · Retrieved 2026-04-11
👤
Insider Activity
1
10 filings
Source ↗
sec_edgar · Retrieved 2026-04-11
Not financial advice. BiotechSigns profiles are AI-generated from verified public sources (ClinicalTrials.gov, SEC EDGAR) and are for informational purposes only. Always do your own due diligence before making investment decisions.
Score Breakdown
Score Trend
2026-04-132026-06-02
Signal Summary
PDUFA Dates1
Insider Filings1
Clinical Trials1
Sector Peers (Gene Editing)
EDITEditas Medicine
C
NTLAIntellia Therapeutics
D
Data Provenance
cik1 verified
clinical trial5 verified
insider buy1 verified
trial count3 verified
Every claim backed by source URL from ClinicalTrials.gov or SEC EDGAR